Latest News
-
Research directs spotlight onto the effectiveness of spinal surgery
Posted on:
New research has found that while the majority of Australian spinal surgeons expect large improvements from common spinal procedures, they say there is only poor quality scientific evidence demonstrating the effectiveness of surgery compared with non-surgical approaches like physiotherapy. A team from the Kolling Institute’s Back Pain Research group and the University of Sydney surveyed
Category:
-
Kolling joins alliance to offer greater support to women in science
Posted on:
The Kolling Institute is stepping up its efforts to foster gender equity in the research sector, joining nearly a dozen leading health and medical research organisations as academic partners of Franklin Women for 2021. Established in 2014, Franklin Women is a professional community dedicated to supporting the careers of women in the health and medical
Category:
-
Researchers to improve diagnosis for genetic disorders
Posted on:
Kolling researchers will drive a large, national research project to improve diagnostic rates for those with mitochondrial diseases and broaden treatment pathways. A $3 million grant from the Medical Research Future Fund is being invested in the project, which will involve clinicians, researchers and diagnostic scientists from a host of organisations including the Kolling and
-
Australian first study to alleviate pain for those with spinal cord injuries
Posted on:
Researchers from the Kolling Institute will partner with international and Australian experts to examine an innovative approach to nerve pain for those with spinal cord injuries. The ground breaking study has been awarded more than $1.78 million through the Federal Government’s Medical Research Future Fund. Professors Ashley Craig, James Middleton and Paul Glare from the
Category:
-
Research to inform new guidelines on the safe use of medicines
Posted on:
Two Royal North Shore Hospital clinician researchers will play a key role in a national research project to improve the use of medications across the community. Head of the Department of Clinical Pharmacology and Kolling researcher Professor Sarah Hilmer and Head of the Department of General Practice Associate Professor Fiona Robinson will help drive the
Category:
-
Recognition for a remarkable career
Posted on:
Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll. Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice and
-
Researchers join celebrations for national award
Posted on:
Kolling Institute researchers have been recognised with a prestigious award for an initiative to support people to return to work after injury. The project, named Early Matched Care at Australia Post, was named the 2021 Winner of Comcare’s national Recovery at and Return to Work Award. The research team was led by Professor Michael Nicholas,
Category:
-
International knee transplant study to inform future care
Posted on:
New funding announced by the Federal Government will see researchers from the Kolling Institute and the University of Sydney drive an international study to determine the best treatment for those with knee cartilage damage. More than $1 million dollars has been awarded through a collaborative research grant scheme involving Australia’s National Health and Medical Research
Category:
-
Kolling researchers join global effort to reduce heart disease in women
Posted on:
Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women. Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioners of The Lancet women
Category:
-
Researchers to identify safer and more effective treatment pathways for rheumatoid and psoriatic arthritis
Posted on:
Kolling researcher Professor Lyn March will lead a large, collaborative national trial to improve treatments and outcomes for those with disabling rheumatoid and psoriatic arthritis. Federal Government MRFF funding will see more than $2.7 million invested in the project which will involve 400 participants across the country. Professor March, who is also the head of
Category: